Pacific Edge posts $14.5m loss as it awaits US Medicare decisions

Pacific Edge posts $14.5m loss as it awaits US Medicare decisions
Pacific Edge chief executive Peter Meintjes says as each day passes, he feels more confident about a favourable decision from Novitas. (Image: Supplied)
John Anthony
Dunedin-headquartered cancer diagnostics company Pacific Edge has posted a $14.5 million after-tax loss for the six months to September 30.The NZX and ASX-listed company said it was awaiting outcomes of several events that had the potential to renew growth in Cxbladder, its urine-based genomic biomarker test for the detection and surveillance of bladder cancer. The events include:Novitas, the Medicare Administrative Contractor (MAC) with responsibility for Pacific Edge’s US lab, making a favourable policy decision on a Local Coverage...

More Markets

NZ sharemarket down 0.2% as Trump retakes office
Markets Market Close

NZ sharemarket down 0.2% as Trump retakes office

The S&P/NZX 50 Index closed at 13.052.9, down 35.41 points or 0.27%.

Graham Skellern 21 Jan 2025
Rua Bioscience psilocybin study targets meth addiction
Markets

Rua Bioscience psilocybin study targets meth addiction

The ‘preparation step’ will be followed by an ‘experiential session’ with the mushroom.

Gregor Thompson 21 Jan 2025
Jarden sees Mercury, Genesis upside
Markets

Jarden sees Mercury, Genesis upside

Energy margin data points to earnings upgrades for both gen-tailers.

Pattrick Smellie 21 Jan 2025
Cooks Coffee continues strong sales growth
Retail

Cooks Coffee continues strong sales growth

The sales growth comes at a time of rapid expansion for the firm.

Staff reporters 21 Jan 2025